Core Insights - Dingdang Health (09886.HK) reported total revenue of RMB 2,326.9 million for the six months ending June 30, 2025, representing a year-on-year increase of 2.6% [1] - The revenue growth is attributed to the optimization of urban layout, focusing on key regions, and enhancing local smart pharmacy networks in cities like Beijing, Shanghai, and Shenzhen [1] - The company's net loss narrowed to RMB 52.0 million, with adjusted net loss at RMB 5.8 million; excluding foreign exchange losses of RMB 4.1 million, the loss would further reduce to RMB 1.7 million [1] - The improvement in loss is linked to an increase in gross margin to 35.0%, up by 1.9 percentage points year-on-year, alongside effective cost reduction and operational efficiency measures [1] Revenue Performance - Total revenue for the six months ending June 30, 2025, was RMB 2,326.9 million, a 2.6% increase compared to the previous year [1] - The growth in revenue is driven by strategic urban development and enhanced service offerings in key metropolitan areas [1] Profitability Metrics - The net loss for the period was reduced to RMB 52.0 million, with an adjusted net loss of RMB 5.8 million [1] - The gross margin improved to 35.0%, reflecting a 1.9 percentage point increase year-on-year, indicating better profitability [1] - Cost control measures and operational improvements have significantly enhanced the company's profitability [1]
叮当健康(09886.HK)中期总收入23.27亿元 同比增长2.6%